Ellen Scherl, MD

Articles by Ellen Scherl, MD

Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity

ByShirley Cohen-Mekelburg, MD, MS,Russell Rosenblatt, MD, MS,Beth Wallace, MD, MS,Nicole Shen, MD, MS,Brett Fortune, MD, MSc,Akbar K. Waljee, MD, MSc,Sameer Saini, MD, MS,Ellen Scherl, MD,Robert Burakoff, MD,Mark Unruh, PhD

October 7th 2019

Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.

Latest Updated Articles

Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity
Published: October 7th 2019 | Updated:

Ellen Scherl, MD

Articles by Ellen Scherl, MD

Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity

Latest Updated Articles

Trending on AJMC

A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform

Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD

Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice

White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx

Smartphone App Reduces Depression in Adults With Intellectual Disabilities